UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy

PloS one, 2014-03, Vol.9 (3), p.e88509

2014

Volltextzugriff (PDF)

A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis

Antimicrobial Agents and Chemotherapy, 2012-12, Vol.56 (12), p.6272-6283

2012

Volltextzugriff (PDF)

End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa

BMC infectious diseases, 2022-12, Vol.22 (1), p.919-919, Article 919

2022

Volltextzugriff (PDF)

Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV Prevention

Pharmaceutics, 2024-03, Vol.16 (3), p.348

2024

Volltextzugriff (PDF)

Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques

PloS one, 2018-05, Vol.13 (5), p.e0197906-e0197906

2018

Volltextzugriff (PDF)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring

Frontiers in cellular and infection microbiology, 2022-03, Vol.12, p.799501

2022

Volltextzugriff (PDF)

Development and Preclinical Investigation of Physically Cross-Linked and pH-Sensitive Polymeric Gels as Potential Vaginal Contraceptives

Polymers, 2022-04, Vol.14 (9), p.1728

2022

Volltextzugriff (PDF)

Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.875-882

2012

Volltextzugriff (PDF)

Topical Inserts: A Versatile Delivery Form for HIV Prevention

Pharmaceutics, 2019-08, Vol.11 (8), p.374

2019

Volltextzugriff (PDF)

Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women

Nutrients, 2020-10, Vol.12 (10), p.3176

2020

Volltextzugriff (PDF)

Characterization of UC781-Tenofovir Combination Gel Products for HIV-1 Infection Prevention in an Ex Vivo Ectocervical Model

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3058-3066

2012

Volltextzugriff (PDF)

Multipurpose Prevention Technologies: Biomedical Tools to Prevent HIV-1, HSV-2, and Unintended Pregnancies

Infectious Diseases in Obstetrics and Gynecology, 2011, Vol.2011 (2011), p.99-108

2011

Volltextzugriff (PDF)

Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention

Pharmaceutics, 2014-12, Vol.6 (4), p.616-631

2014

Volltextzugriff (PDF)

Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir

Biomaterials, 2017-11, Vol.144, p.144-154

2017

Volltextzugriff (PDF)

Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial

Translational medicine communications, 2021-09, Vol.6 (1), p.1-9, Article 21

2021

Volltextzugriff (PDF)

A new approach for discriminating spatially acquired SERS spectra using antiretroviral drug emtricitabine as a test sample

Journal of Raman spectroscopy, 2024-11, Vol.55 (11), p.1129-1138

2024

Volltextzugriff (PDF)

Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa

AIDS and behavior, 2024-03, Vol.28 (3), p.936-950

2024

Volltextzugriff (PDF)

The use of objective adherence measures targeting four placebo microbicide delivery forms in the Quatro Clinical Crossover Study

Clinical and translational discovery, 2021-10, Vol.1 (1), p.n/a

2021

Volltextzugriff (PDF)

Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges

Expert opinion on drug delivery, 2022-10, Vol.19 (10), p.1365-1380

2022

Volltextzugriff (PDF)

HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa

AIDS and behavior, 2022-09, Vol.26 (9), p.3099-3109

2022

Volltextzugriff (PDF)

Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques

The Journal of infectious diseases, 2024-06, Vol.229 (6), p.1791-1795

2024

Volltextzugriff (PDF)

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies

Clinical and translational medicine, 2018-11, Vol.7 (1), p.1-11

2018

Volltextzugriff (PDF)

Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population

Pain medicine (Malden, Mass.), 2018-07, Vol.19 (7), p.1382-1395

2018

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(159)

Publikationsform

Artikel
(196)
Buchkapitel
(2)

Sprache

Englisch
(198)

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(122)
Humans
(91)
Female
(71)
Male
(43)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Adult
(26)
Pharmacology & Pharmacy
(26)
Middle Aged
(25)
Covid-19
(24)
Human Immunodeficiency Virus
(24)
Hiv
(23)
Hiv Infections - Prevention & Control
(23)
Infectious Diseases
(21)
Physical Sciences
(20)
Animals
(18)
Tenofovir
(18)
Adolescent
(17)
Aged
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis

End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa

Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV Prevention

Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring

Development and Preclinical Investigation of Physically Cross-Linked and pH-Sensitive Polymeric Gels as Potential Vaginal Contraceptives

Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring

Topical Inserts: A Versatile Delivery Form for HIV Prevention

Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women

Characterization of UC781-Tenofovir Combination Gel Products for HIV-1 Infection Prevention in an Ex Vivo Ectocervical Model

Multipurpose Prevention Technologies: Biomedical Tools to Prevent HIV-1, HSV-2, and Unintended Pregnancies

Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention

Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir

Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial

A new approach for discriminating spatially acquired SERS spectra using antiretroviral drug emtricitabine as a test sample

Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa

The use of objective adherence measures targeting four placebo microbicide delivery forms in the Quatro Clinical Crossover Study

Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges

HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa

Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies

Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population

Suchergebnisse filtern